Navigation Links
Lycera Closes $36 Million Series A Financing
Date:4/16/2009

ANN ARBOR, Mich., April 16 /PRNewswire/ -- Lycera Corp. today announced it has closed a $36 million Series A financing.

The company, which is developing novel small-molecule pharmaceuticals to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, has received $10 million as a first tranche of the financing and will receive the remainder of the proceeds in two tranches as specific milestones are met. InterWest Partners, ARCH Venture Partners and Clarus Ventures co-led the financing. EDF Ventures, which led a seed financing in November 2006, is also participating.

In conjunction with the closing, Jeffrey Leiden, M.D., Ph.D., a managing director with Clarus; Kristina Burow, a partner with ARCH; and Nina Kjellson, a general partner with InterWest, have joined Lycera's board of directors. These additions have increased board membership to six. Steven Gillis, Ph.D., a managing director with ARCH, and Mary Campbell, a managing director at EDF Ventures, will serve as board observers.

Lycera also announced that it has expanded its development initiatives for small-molecule immunomodulators through the addition of a program targeting the Th17 pathway discovered by Dan Littman, M.D., Ph.D. Dr. Littman, the Helen L. and Martin S. Kimmel professor of molecular immunology and professor of pathology and microbiology at the Skirball Institute of Biomolecular Medicine of New York University School of Medicine, an investigator of the Howard Hughes Medical Institute, and a member of the National Academy of Sciences, will serve as chairman of the company's scientific advisory board.

"This financing round is an important validation of the Lycera technology platforms," said Dr. Gary Glick, Lycera's founder and chief scientific officer. "The company is fortunate to be working with a distinguished, talented and experienced group of investors. Their expertise in the dis
'/>"/>

SOURCE Lycera Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
2. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
3. Cell Biosciences Closes $10 Million Series C Financing
4. Index Ventures Closes Euro 350 Million Early Stage Fund
5. Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm
6. Opsona Therapeutics Closes EUR18M Funding
7. iCo Therapeutics Closes $1.3 Million Private Placement
8. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
9. Lytix Closes USD 10.4 Million Funding Round
10. Singulex Closes $19 Million Financing Round
11. Karolinska Development Closes Fully Subscribed New Share Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of autologous ... out of the University of Calgary in conjunction with ... Carolina, which further validates the company,s ongoing clinical research ... effects of pattern baldness. The paper entitled ...
(Date:12/22/2014)... MISSION VIEJO, Calif. , Dec. 22, 2014 /PRNewswire/ ... announce that CoPatient, an online medical bill review and ... newest offering in the FREE WellCard Savings discount health ... a medical bill that was more than they expected ... help members reduce health care costs, WellCard Savings is ...
(Date:12/22/2014)... Memphis, TENN (PRWEB) December 22, 2014 ... with Donor Egg Bank USA , a network ... the country. Through this partnership, patients have fast access ... for in vitro fertilization, IVF . Fertility Associates of ... to offer this fertility treatment option. , Dr. ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... Life Technologies Corporation (NASDAQ: LIFE ) ... Stock Conference on Tuesday, May 10 at 9:45am CT. ... will present on behalf of the company. The company ... three weeks following the conference on the Life Technologies, ...
... Here, Inc., and Richards Partners have been selected ... a wholly owned subsidiary of International Stem Cell ... on therapeutic and research products.  Lifeline offers luxury ... stem cell technology.  Based in Dallas and part ...
... promise of superfast computers and ultrapowerful optical microscopes ... of the hottest fields in high-technology. However, to ... that feature interfaces between noble metals and dielectrics. ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ...
Cached Biology Technology:Life Technologies to Present at Baird's 2011 Growth Stock Conference 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 2Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners 3New kid on the plasmonic block 2New kid on the plasmonic block 3New kid on the plasmonic block 4New kid on the plasmonic block 5
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be ... Acuity Market Intelligence reports that the long anticipated ... Acuity forecasts that intensifying demand for smart phones, ... will drive a global market of 2.5 billion ... 2020.   According to Maxine ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research ... announced the addition of the "Samsung Galaxy ... Analysis" report to their offering. ... on a totally different sensing technology than the ... a fingerprint sensor in its product. ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... kill bacteria could be making them stronger, according to ... journal Microbiology . Low levels of these chemicals, ... aureus remove toxic chemicals from the cell even more ... some antibiotics. Biocides are used in disinfectants and ...
... Top 100 Internet Retailers, BOISE, Idaho, Oct. ... provider of fraud control for ecommerce merchants, has ... National Account Sales,directors. Together, they bring Kount customers ... ecommerce fraud control and online,payments., Scott Lewer ...
... New Haven, Conn. Yale researchers have harnessed the power ... in 1916 that plants with rapid reproductive cycles evolve ... Science . "Our study has profound consequence for ... of the computer in revealing major evolutionary patterns," said senior ...
Cached Biology News:Disinfectants can make bacteria resistant to treatment 2Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2Reproducing early and often is the key to rapid evolution in plants 2
A convenience pack containing one each of the most popular sizes of Cat. No. 4980 flask. Designed for the low volume user, a case contains one each of five sizes: 50mL, 125mL, 250mL, 500mL, and 1L....
... The Adept HPLC range has ... Q-Adept systems, a quaternary low ... binary low pressure mixing pump. ... compact systems add even more ...
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)...
... polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide derived ... 178-227 of human YBX2. (Note: ... proprietary). ...
Biology Products: